Recap: Usana Health Sciences Q4 Earnings
Portfolio Pulse from Benzinga Insights
Usana Health Sciences (NYSE:USNA) reported Q4 earnings with an EPS of $0.87, beating estimates by 67.31% but with a revenue decrease of $6.88 million from the previous year. The company had previously missed EPS estimates last quarter, leading to an 18.0% share price drop the following day.

February 06, 2024 | 9:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Usana Health Sciences reported a significant beat on Q4 earnings estimates but saw a decrease in revenue compared to last year. The company's history shows a stock price drop following an earnings miss last quarter.
The significant beat on earnings estimates is likely to positively impact investor sentiment and potentially the stock price in the short term, despite the revenue decrease. Historical performance indicates sensitivity to earnings reports.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100